Chihui Liang

ChiHui (CH) Liang has a strong background in research and development, with expertise in immunology, protein-based therapies, and antibody engineering. Starting in 2007, they worked as an Academia Sinica Postdoctoral Fellow at the Genomics Research Center in Taiwan, where they focused on investigating the role of glycosylation in immune responses and designing glycan profiling assays. From 2012 to 2015, they were a Postdoctoral Research Associate at Scripps Research, where they gained experience in biologics expression, purification, and drug discovery processes. They then joined the Ragon Institute of MGH, MIT, and Harvard as a Senior Postdoctoral Research Associate, specializing in HIV/AIDS, global infectious diseases, and vaccine development. Since 2017, ChiHui has been working at Cue Health, initially as the Director of Research Development and currently as the Sr. Director of Research Development/Sr. Director of Biomanufacturing. In this role, they have led projects to develop high-quality point-of-care mobile health devices, explored new scientific technologies, and optimized production speed and quality.

ChiHui (CH) Liang completed a Doctor of Philosophy (PhD) degree in Chemical Engineering and Materials science from the University of Southern California from 2002 to 2007. Additionally, ChiHui Liang obtained certifications in "High throughput Liquid handling and automation system" from Tecan and "Lean Six Sigma Black Belt" from LinkedIn, although the specific dates of completion are not provided.